Market Cap (In AUD)
5.35 Million
Revenue (In AUD)
-
Net Income (In AUD)
324.21 Thousand
Avg. Volume
185.58 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.033-0.078
- PE
- -
- EPS
- -
- Beta Value
- 0.564
- ISIN
- AU0000012973
- CUSIP
- Q6644N100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Anthony James Keating
- Employee Count
- -
- Website
- https://www.neuroscientific.com
- Ipo Date
- 2018-07-27
- Details
- NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.
More Stocks
-
INSECTICIDInsecticides (India) Limited
INSECTICID
-
TCNT
-
RCI-A
-
HITECHCORPHitech Corporation Limited
HITECHCORP
-
VPBNVP Bank AG
VPBN
-
BIGG
-
029460KC Co., Ltd.
029460
-
1925